Subscribe
Back to list

Marc Gorelick, MD

President and CEO

Children’s Minnesota

Minneapolis, MN

Dr. Gorelick, president and CEO of Children’s Minnesota, is a dedicated advocate for children’s health and wellbeing, both within hospital walls and throughout the community. He actively addresses social determinants of health, recognizing their role in improving outcomes for kids. Dr. Gorelick has been a vocal supporter of transgender and gender-diverse youth, publicly condemning restrictive healthcare policies and affirming Children’s Minnesota’s commitment to inclusive care. He has also testified in favor of anti-discrimination legislation, such as the “CROWN Act”, which is now law in Minnesota. In his upcoming book, he shifts the national conversation on gun violence from politics to public health, emphasizing its status as the leading cause of death among children and advocating for evidence-based solutions. His leadership extends beyond healthcare, as evidenced by his appointment to Minnesota’s Equitable Health Care task force, where he works to eliminate health disparities statewide. Recognized as a “Most Admired CEO” by the Minneapolis/St. Paul Business Journal in 2020, Dr. Gorelick consistently leverages his platform to champion policies and initiatives that support children’s health and safety. Dr. Gorelick has announced his intention to retire in July 2025 following a 42-year career in medicine.

Becker's Recognition

Marc Gorelick, MDhas been named a Becker's honoree on the lists below.

2025 Winner

Executives

Great Leaders in Healthcare

Healthcare is rapidly evolving and the best leaders have embraced change and are leading organizations on the forefront of transforming care delivery. The below leaders are using innovative digital technology, novel care delivery approaches and creative care solutions to shape the future of healthcare.

Newsletter

Join the 500,000+
healthcare executives
who start their day with
Becker’s

You can unsubscribe from these communications at any time. For more information, please review
our Privacy Policy.
More Newsletters